| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 14.242 | 14.247 | 14.146 | 13.769 | 12.342 | 9.831 | 12.206 | 12.302 | 12.187 | 12.187 |
| Total Income - EUR | 14.242 | 14.299 | 14.198 | 13.884 | 12.455 | 9.839 | 12.211 | 12.547 | 12.187 | 12.321 |
| Total Expenses - EUR | 4.766 | 4.105 | 3.957 | 4.407 | 4.064 | 3.557 | 3.563 | 3.615 | 3.636 | 3.561 |
| Gross Profit/Loss - EUR | 9.476 | 10.194 | 10.241 | 9.477 | 8.391 | 6.281 | 8.648 | 8.932 | 8.551 | 8.760 |
| Net Profit/Loss - EUR | 7.960 | 9.765 | 9.815 | 9.060 | 8.017 | 5.986 | 8.282 | 8.555 | 7.167 | 7.359 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Medifarm Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 58.897 | 56.759 | 54.288 | 51.423 | 33.909 | 31.864 | 29.795 | 28.520 | 26.969 | 25.463 |
| Current Assets | 3.380 | 2.887 | 4.148 | 5.267 | 5.213 | 4.640 | 8.389 | 9.909 | 10.146 | 4.014 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 2.830 | 2.773 | 2.541 | 2.472 | 2.413 | 2.366 | 2.325 | 222 | 1.247 | 3.341 |
| Cash | 549 | 114 | 1.608 | 2.795 | 2.800 | 2.274 | 6.064 | 9.687 | 8.898 | 673 |
| Shareholders Funds | 56.958 | 58.264 | 57.493 | 55.863 | 38.851 | 36.236 | 37.860 | 38.225 | 36.747 | 28.033 |
| Social Capital | 249 | 246 | 242 | 237 | 233 | 228 | 223 | 224 | 223 | 222 |
| Debts | 5.318 | 1.382 | 943 | 827 | 271 | 268 | 323 | 203 | 368 | 1.445 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4775 - 4775" | |||||||||
| CAEN Financial Year |
6820
|
|||||||||
Comments - Medifarm Srl